RSU1 (Ras Suppressor Protein 1) is a cellular protein that plays a significant role in the regulation of integrin signaling and cell adhesion, impacting cellular processes such as migration, proliferation, and survival. The protein functions within the PINCH-ILK-PARVIN complex, a critical component of focal adhesions that mediate the transduction of signals from the extracellular matrix to the actin cytoskeleton. Through its interactions, RSU1 influences the regulation of integrin signaling pathways, modulating the dynamics of cell adhesion and the response to extracellular signals. This regulatory role is crucial for the proper maintenance of cellular architecture, the response to mechanical stress, and the orchestration of cell movement, highlighting the importance of RSU1 in tissue development and homeostasis, as well as in the response to injury.
The inhibition of RSU1 disrupts normal cell adhesion and signaling processes, potentially leading to altered cellular responses to environmental cues, impaired migration, and changes in proliferation rates. Mechanistically, the inhibition of RSU1 can occur through several pathways, including the downregulation of its expression, interference with its ability to interact with other components of the PINCH-ILK-PARVIN complex, or through post-translational modifications that affect its function or stability. Such inhibitory actions could impact the integrin signaling pathways, leading to modifications in cellular adherence to the extracellular matrix and changes in the transmission of mechanical or chemical signals within the cell. This disruption of RSU1 function can have significant implications, affecting not only cell motility and proliferation but also the potential for cells to undergo phenotypic changes in response to alterations in their microenvironment. Understanding the mechanisms through which RSU1 is inhibited provides insights into the complex regulation of cell adhesion and signaling, offering potential avenues for exploring how disruptions in these processes contribute to various pathological conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
Displaces Ras from cell membranes, thereby inhibiting its function and downstream signaling. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of farnesyltransferase, preventing Ras protein farnesylation and membrane association. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
Inhibits geranylgeranyltransferase I, which is necessary for the activation of some Rho family GTPases, influencing integrin signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which disrupts the PI3K/AKT pathway that can be regulated by Ras. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
A farnesyltransferase inhibitor that prevents the farnesylation and activation of Ras proteins. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
Another farnesyltransferase inhibitor that blocks Ras activation. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
C-Raf kinase inhibitor, thereby influencing the MAPK/ERK pathway affected by Ras. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Specifically disrupts Rac1 interaction with its guanine nucleotide exchange factors. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
Inhibits RhoA transcriptional signaling, which can be downstream of integrin signaling. | ||||||